Walleye Capital
GILD icon

Walleye Capital’s Gilead Sciences GILD Stock Holding History

Walleye Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.26M Sell
33,700
-99,200
-75% -$13.1M 0.02% 926
2026
Q1 		$18.5M Sell
132,900
-106,600
-45% -$14.9M 0.08% 220
2025
Q4 		$29.4M Buy
239,500
+105,600
+79% +$12.8M 0.09% 165
2025
Q3 		$14.9M Sell
133,900
-37,900
-22% -$4.31M 0.06% 364
2025
Q2 		$19M Buy
171,800
+84,900
+98% +$9.04M 0.07% 251
2025
Q1 		$9.74M Sell
86,900
-26,400
-23% -$2.72M 0.04% 455
2024
Q4 		$10.5M Buy
113,300
+60,200
+113% +$5.42M 0.03% 602
2024
Q3 		$4.45M Sell
53,100
-3,700
-7% -$282K 0.01% 1258
2024
Q2 		$3.9M Sell
56,800
-50,100
-47% -$3.34M 0.01% 1489
2024
Q1 		$7.83M Sell
106,900
-86,200
-45% -$6.63M 0.01% 986
2023
Q4 		$15.6M Sell
193,100
-28,000
-13% -$2.18M 0.03% 450
2023
Q3 		$16.6M Buy
221,100
+145,600
+193% +$11.2M 0.04% 333
2023
Q2 		$5.82M Buy
75,500
+53,900
+250% +$4.3M 0.02% 648
2023
Q1 		$1.79M Sell
21,600
-15,100
-41% -$1.25M 0.03% 789
2022
Q4 		$3.15M Buy
36,700
+25,500
+228% +$2.02M 0.06% 397
2022
Q3 		$691K Buy
+11,200
New +$706K 0.01% 1222
2020
Q2 		– Sell
-500
Closed -$37K – 748
2020
Q1 		$37K Sell
500
-27,300
-98% -$1.89M 0.01% 715
2019
Q4 		$1.81M Sell
27,800
-66,500
-71% -$4.33M 0.12% 230
2019
Q3 		$5.98M Buy
94,300
+84,600
+872% +$5.53M 0.36% 40
2019
Q2 		$655K Sell
9,700
-7,000
-42% -$460K 0.07% 396
2019
Q1 		$1.09M Buy
+16,700
New +$1.11M 0.18% 139

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walleye Capital's GILD Position: Q2 2026 in Review

Walleye Capital reduced its Gilead Sciences (GILD) stake by 99% in Q2 2026, selling an estimated $19.7M and leaving 1,222 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

Walleye Capital first reported a position in GILD in Q1 2019 and has held it in 15 quarters since. The position peaked at $21M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Walleye Capital held 1,222 shares of Gilead Sciences worth $154K as of Q2 2026.
  • Walleye Capital sold 149,745 Gilead Sciences shares in Q2 2026, an estimated $19.7M.
  • Gilead Sciences made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3652 holding.
  • Walleye Capital first reported a position in Gilead Sciences in Q1 2019 and has held it in 15 quarters since.
  • Walleye Capital's Gilead Sciences position peaked at $21M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.